20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas

David Bellocq (1) , Pascal Roy (2, 3, 4) , Laurent Kodjikian (5, 6) , Thibaud Mathis (7) , Anh-Minh Nguyen , Joël Hérault (8) , Michel Rivoire (9) , Sylvie Négrier (9) , Juliette Thariat (10, 11) , Jean-Daniel Grange

1 CHU Pitié-Salpêtrière [AP-HP]
2 LBBE - Laboratoire de Biométrie et Biologie Evolutive - UMR 5558
3 Service de Biostatistiques [Lyon]
4 HCL - Hospices Civils de Lyon
5 Hôpital de la Croix-Rousse [CHU - HCL]
6 MATEIS - Matériaux, ingénierie et science [Villeurbanne]
7 Inserm U968/CNRS UMR7210/UPMC UM80 - Equipe 14 - Inflammation dans la dégénérescence neuronale et le remodelage vasculaire
8 UNICANCER/CAL - Centre de Lutte contre le Cancer Antoine Lacassagne [Nice]
9 Centre Léon Bérard [Lyon]
10 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]
11 Advanced Resource Centre for HADrontherapy in Europe - ARCHADE

Domaines: Physique [physics]

David Bellocq, Pascal Roy, Laurent Kodjikian, Thibaud Mathis, Anh-Minh Nguyen, et al.. 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas. Melanoma Research, 2020, 30, pp.272-278. ⟨10.1097/CMR.0000000000000519⟩. ⟨hal-03368075⟩